{"id":295700,"date":"2019-10-02T22:48:36","date_gmt":"2019-10-03T05:48:36","guid":{"rendered":"https:\/\/nai500.com\/?p=295700"},"modified":"2019-10-02T22:48:36","modified_gmt":"2019-10-03T05:48:36","slug":"%e4%b8%ad%e5%9c%8b%e6%81%92%e6%bd%a4%e9%81%94%e7%94%9f%e5%ae%8c%e6%88%90b%e8%bc%aa%e8%9e%8d%e8%b3%87","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2019\/10\/%e4%b8%ad%e5%9c%8b%e6%81%92%e6%bd%a4%e9%81%94%e7%94%9f%e5%ae%8c%e6%88%90b%e8%bc%aa%e8%9e%8d%e8%b3%87\/","title":{"rendered":"\u4e2d\u570b\u6052\u6f64\u9054\u751f\u5b8c\u6210B\u8f2a\u878d\u8cc7"},"content":{"rendered":"<p>\u4e0a\u6d77\u6052\u6f64\u9054\u751f\u751f\u7269\u79d1\u6280\u6709\u9650\u516c\u53f8\u5b8c\u6210B\u8f2a$2800\u842c\u878d\u8cc7\uff0c\u672c\u8f2a\u878d\u8cc7\u7531\u6df1\u5275\u6295\u9818\u6295\u3002\u6052\u6f64\u9054\u751f\u4f4d\u65bc\u4e0a\u6d77\u7684\u5f35\u6c5f\u9ad8\u79d1\u6280\u5712\u5340\u3002\u8a72\u516c\u53f8\u4e8e2015\u5e74\u6210\u7acb\uff0c\u64c1\u6709\u201c\u4e00\u500b\u4e2d\u5fc3\u548c\u591a\u500b\u4eae\u9ede\u201d\u3002\u6052\u6f64\u9054\u751f\u7684\u4e3b\u8981\u91cd\u9ede\u662fCAR-T\u7522\u54c1\uff0c\u4f46\u5b83\u4e5f\u5728\u958b\u767c\u4f7f\u7528CAR-Natural Killer Cells\uff08\u57fa\u65bc\u6a39\u7a81\u7d30\u80de\u7684\u764c\u75c7\u75ab\u82d7\uff09\u7684\u5176\u4ed6\u7522\u54c1\u3002\u6052\u6f64\u9054\u751f\u5df2\u958b\u59cb\u5c0d\u5176\u5169\u7a2eCAR-T\u7642\u6cd5\u9032\u884c\u4e2d\u570b\u81e8\u5e8a\u8a66\u9a57\u3002<\/p>\n<p>\u82f1\u6587\u4f86\u6e90\uff1aChina Biotoday<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Shanghai Hrain Biotechnology, a clinical-stage oncology immunotherapy company, raised $28 million in a Series B round led by Shenzhen Capital. Hrain is located in Shanghai&#8217;s Zhangjiang Hi-Tech Park. Founded in 2015 by returnees, the company has &#8220;one center and multiple highlights.&#8221; Its major emphasis is CAR-T products, but it also is developing other products using CAR-Natural Killer Cells, dendritic cell-based cancer vaccines. and invariant natural killer T cells. Hrain has started China clinical trials for two of its CAR-T therapies. <\/p>\n","protected":false},"author":9,"featured_media":295694,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[426],"tags":[563],"class_list":["post-295700","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hant","tag--zh-hant","sectors-life-science-zh-hant","locations-china-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/295700","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=295700"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/295700\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/295694"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=295700"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=295700"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=295700"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}